Quince Therapeutics, Inc. Increase (Decrease) in Other Current Assets
Quince Therapeutics, Inc. (QNCX) reported Increase (Decrease) in Other Current Assets of -$1.77 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherCurrentAssets · last filed 2026-08-14
- Quince Therapeutics, Inc. increase (decrease) in other current assets for the quarter ending 2026-06-30 was $8.00K, a 97.18% decline year-over-year.
- Quince Therapeutics, Inc. increase (decrease) in other current assets for the quarter ending 2026-03-31 was -$1.78M.
- Quince Therapeutics, Inc. increase (decrease) in other current assets for the quarter ending 2025-12-31 was -$4.81M, a 1171.49% decline year-over-year.
- Quince Therapeutics, Inc. increase (decrease) in other current assets for the quarter ending 2025-09-30 was $486.00K, a 179.31% increase year-over-year.
- Quince Therapeutics, Inc. increase (decrease) in other current assets for fiscal 2025 was -$4.20M, a 667.34% decline from fiscal 2024.
- Quince Therapeutics, Inc. increase (decrease) in other current assets for fiscal 2024 was $741.00K, a 8133.33% increase from fiscal 2023.
- Quince Therapeutics, Inc. increase (decrease) in other current assets for fiscal 2023 was $9.00K.
- Quince Therapeutics, Inc. increase (decrease) in other current assets for fiscal 2022 was -$194.00K, a 225.16% decline from fiscal 2021.
| Period end | Increase (Decrease) in Other Current Assets 3 month | Increase (Decrease) in Other Current Assets 6 month | Increase (Decrease) in Other Current Assets 9 month | Increase (Decrease) in Other Current Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $8.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$1.77M 10-Q · filed 2026-08-14 | -$6.58M derived: sum of 3 quarters · filed 2026-08-14 | -$6.10M derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | -$1.78M 10-Q · filed 2026-05-11 | -$6.59M derived: sum of 2 quarters · filed 2026-05-11 | -$6.11M derived: sum of 3 quarters · filed 2026-05-11 | -$5.82M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | -$4.81M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-10 | -$4.33M derived: sum of 2 quarters · filed 2026-04-10 | -$4.04M derived: sum of 3 quarters · filed 2026-08-14 | -$4.20M 10-K · filed 2026-04-10 |
| 2025-09-30 | $486.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $770.00K derived: sum of 2 quarters · filed 2026-08-14 | $607.00K 10-Q · filed 2025-11-12 | $1.06M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $284.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $121.00K 10-Q · filed 2026-08-14 | $570.00K derived: sum of 3 quarters · filed 2026-08-14 | $744.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | -$163.00K 10-Q · filed 2026-05-11 | $286.00K derived: sum of 2 quarters · filed 2026-05-11 | $460.00K derived: sum of 3 quarters · filed 2026-05-11 | $570.00K derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | $449.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-10 | $623.00K derived: sum of 2 quarters · filed 2026-04-10 | $733.00K derived: sum of 3 quarters · filed 2026-04-10 | $741.00K 10-K · filed 2026-04-10 |
| 2024-09-30 | $174.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $284.00K derived: sum of 2 quarters · filed 2025-11-12 | $292.00K 10-Q · filed 2025-11-12 | $301.00K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $110.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $118.00K 10-Q · filed 2025-08-11 | $127.00K derived: sum of 3 quarters · filed 2025-08-11 | $127.00K derived: sum of 4 quarters · filed 2025-08-11 |
| 2024-03-31 | $8.00K 10-Q · filed 2025-05-13 | $17.00K derived: sum of 2 quarters · filed 2025-05-13 | $17.00K derived: sum of 3 quarters · filed 2025-05-13 | $17.00K derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $9.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | $9.00K derived: sum of 2 quarters · filed 2025-03-24 | $9.00K derived: sum of 3 quarters · filed 2025-03-24 | $9.00K 10-K · filed 2025-03-24 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $0.00 derived: sum of 2 quarters · filed 2024-11-13 | $0.00 10-Q · filed 2024-11-13 | -$19.00K derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $0.00 10-Q · filed 2024-08-13 | -$19.00K derived: sum of 3 quarters · filed 2024-08-13 | -$47.00K derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-13 | -$19.00K derived: sum of 2 quarters · filed 2024-05-13 | -$47.00K derived: sum of 3 quarters · filed 2024-05-13 | -$29.00K derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | -$19.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | -$47.00K derived: sum of 2 quarters · filed 2024-04-01 | -$29.00K derived: sum of 3 quarters · filed 2024-04-01 | -$194.00K 10-K · filed 2024-04-01 |
| 2022-09-30 | -$28.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$10.00K derived: sum of 2 quarters · filed 2023-11-14 | -$175.00K 10-Q · filed 2023-11-14 | -$174.00K derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $18.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$147.00K 10-Q · filed 2023-08-03 | -$146.00K derived: sum of 3 quarters · filed 2023-08-03 | -$98.00K derived: sum of 4 quarters · filed 2023-08-03 |
| 2022-03-31 | -$165.00K 10-Q · filed 2023-05-15 | -$164.00K derived: sum of 2 quarters · filed 2023-05-15 | -$116.00K derived: sum of 3 quarters · filed 2023-05-15 | |
| 2021-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | $49.00K derived: sum of 2 quarters · filed 2023-03-15 | $155.00K 10-K · filed 2023-03-15 | |
| 2021-09-30 | $48.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $154.00K 10-Q · filed 2022-11-09 | ||
| 2021-06-30 | $106.00K 10-Q · filed 2022-08-09 | |||
| 2020-09-30 | -$35.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-29 | -$8.00K 10-Q · filed 2021-10-29 | ||
| 2020-06-30 | $27.00K 10-Q · filed 2021-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |